Furthermore, multiple single-cell technologies have characterized the heterogeneity of the tumor immune microenvironment, and a significant enrichment of suppressive Tregs was first revealed in the low TP53 score group, where the underlying mechanism might be an extensive and dynamic crosstalk between cancer and immunosuppressive cells. The gene discussed is TP53; the disease is cancer.